{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:41:46Z","timestamp":1792201306882,"version":"4.4.0"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The authors set out to study whether autosomal dominant polycystic kidney disease (ADPKD), an established risk factor for intracranial aneurysms (IAs), affects the acute course and long-term outcome of aneurysmal subarachnoid hemorrhage (aSAH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The outcomes of 32 ADPKD patients with aSAH between 1980 and 2015 (median age 43 years; 50% women) were compared with 160 matched (age, sex, and year of aSAH) non-ADPKD aSAH patients in the prospectively collected Kuopio Intracranial Aneurysm Patient and Family Database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>At 12 months, 75% of the aSAH patients with ADPKD versus 71% of the matched-control aSAH patients without ADPKD had good outcomes (Glasgow Outcome Scale score 4 or 5). There was no significant difference in condition at admission. Hypertension had been diagnosed before aSAH in 69% of the ADPKD patients versus 27% of controls (p &lt; 0.001). Multiple IAs were present in 44% of patients in the ADPKD group versus 25% in the control group (p = 0.03). The most common sites of ruptured IAs were the anterior communicating artery (47% vs 29%, p = 0.05) and the middle cerebral artery bifurcation (28% vs 31%), and the median size was 6.0 mm versus 8.0 mm (p = 0.02). During the median follow-up of 11 years, a second aSAH occurred in 3 of 29 (10%) ADPKD patients and in 4 of 131 (3%) controls (p = 0.11). A fatal second aSAH due to a confirmed de novo aneurysm occurred in 2 (6%) of the ADPKD patients but in none of the controls (p = 0.027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The outcomes of ADPKD patients with aSAH did not differ significantly from those of matched non-ADPKD aSAH patients. ADPKD patients had an increased risk of second aSAH from a de novo aneurysm, warranting long-term angiographic follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.4.jns20544","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T03:47:11Z","timestamp":1601610431000},"page":"1871-1878","source":"Crossref","is-referenced-by-count":5,"title":["Lack of impact of polycystic kidney disease on the outcome of aneurysmal subarachnoid hemorrhage: a matched case-control study"],"prefix":"10.3171","volume":"134","author":[{"given":"Heidi J.","family":"Nurmonen","sequence":"first","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"},{"name":"Kuopio Health Center, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Huttunen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Huttunen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arttu","family":"Kurtelius","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Kotikoski","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Junkkari","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Koivisto","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"von und zu Fraunberg","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli-Pekka","family":"K\u00e4m\u00e4r\u00e4inen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit","family":"L\u00e5ng","sequence":"additional","affiliation":[{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"},{"name":"Neurointensive Care and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Isoniemi","sequence":"additional","affiliation":[{"name":"Transplantation and Liver Surgery Clinic, Abdominal Center, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha E.","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti E.","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and University of Eastern Finland, Kuopio;"},{"name":"School of Medicine, Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio;"},{"name":"Department of Clinical Radiology, Kuopio University Hospital, Kuopio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"10174","key":"b1","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall\n \nE","year":"2019","unstructured":"Cornec-Le Gall\n \nE\n\n, \n\nAlam\n \nA\n\n, \n\nPerrone\n \nRD\n\n\n. \nAutosomal dominant polycystic kidney disease\n. \nLancet\n. \n2019\n;\n393\n(\n10174\n):\n919\n\u2013\n935\n.\n10.1016\/S0140-6736(18)32782-X30819518"},{"issue":"8","key":"b2","series-title":"Nephrol Dial Transplant","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey\n \nCJ","year":"2017","unstructured":"Willey\n \nCJ\n\n, \n\nBlais\n \nJD\n\n, \n\nHall\n \nAK\n\n, \n\n\n \nPrevalence of autosomal dominant polycystic kidney disease in the European Union\n. \nNephrol Dial Transplant\n. \n2017\n;\n32\n(\n8\n):\n1356\n\u2013\n1363\n.\n27325254"},{"issue":"10","key":"b3","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree\n \nMB","year":"2018","unstructured":"Lanktree\n \nMB\n\n, \n\nHaghighi\n \nA\n\n, \n\nGuiard\n \nE\n\n, \n\n\n \nPrevalence estimates of polycystic kidney and liver disease by population sequencing\n. \nJ Am Soc Nephrol\n. \n2018\n;\n29\n(\n10\n):\n2593\n\u2013\n2600\n.\n10.1681\/ASN.201805049330135240"},{"issue":"9","key":"b4","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history","volume":"28","author":"Iliuta\n \nI-A","year":"2017","unstructured":"Iliuta\n \nI-A\n\n, \n\nKalatharan\n \nV\n\n, \n\nWang\n \nK\n\n, \n\n\n \nPolycystic kidney disease without an apparent family history\n. \nJ Am Soc Nephrol\n. \n2017\n;\n28\n(\n9\n):\n2768\n\u2013\n2776\n.\n2852268810.1681\/ASN.2016090938"},{"issue":"9569","key":"b5","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres\n \nVE","year":"2007","unstructured":"Torres\n \nVE\n\n, \n\nHarris\n \nPC\n\n, \n\nPirson\n \nY\n\n\n. \nAutosomal dominant polycystic kidney disease\n. \nLancet\n. \n2007\n;\n369\n(\n9569\n):\n1287\n\u2013\n1301\n.\n1743440510.1016\/S0140-6736(07)60601-1"},{"issue":"10","key":"b6","series-title":"Nephrol Dial Transplant","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/ndt\/gfu087","article-title":"Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure","volume":"29","author":"Shaw\n \nC","year":"2014","unstructured":"Shaw\n \nC\n\n, \n\nSimms\n \nRJ\n\n, \n\nPitcher\n \nD\n\n, \n\nSandford\n \nR\n\n\n. \nEpidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure\n. \nNephrol Dial Transplant\n. \n2014\n;\n29\n(\n10\n):\n1910\n\u2013\n1918\n.\n2473744410.1093\/ndt\/gfu087"},{"issue":"4","key":"b7","series-title":"Am J Kidney Dis","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2014.05.020","article-title":"ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010","volume":"64","author":"Reule\n \nS","year":"2014","unstructured":"Reule\n \nS\n\n, \n\nSexton\n \nDJ\n\n, \n\nSolid\n \nCA\n\n, \n\n\n \nESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010\n. \nAm J Kidney Dis\n. \n2014\n;\n64\n(\n4\n):\n592\n\u2013\n599\n.\n10.1053\/j.ajkd.2014.05.02025134777"},{"issue":"3","key":"b8","series-title":"Drugs","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-019-1056-1","article-title":"Tolvaptan: a review in autosomal dominant polycystic kidney disease","volume":"79","author":"Blair\n \nHA","year":"2019","unstructured":"Blair\n \nHA\n\n\n. \nTolvaptan: a review in autosomal dominant polycystic kidney disease\n. \nDrugs\n. \n2019\n;\n79\n(\n3\n):\n303\n\u2013\n313\n.\n10.1007\/s40265-019-1056-130689194"},{"issue":"1","key":"b9","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects","volume":"12","author":"Ecder\n \nT","year":"2001","unstructured":"Ecder\n \nT\n\n, \n\nSchrier\n \nRW\n\n\n. \nHypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects\n. \nJ Am Soc Nephrol\n. \n2001\n;\n12\n(\n1\n):\n194\n\u2013\n200\n.\n1113426710.1681\/ASN.V121194"},{"issue":"4","key":"b10","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","article-title":"Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage","volume":"10","author":"Rinkel\n \nGJE","year":"2011","unstructured":"Rinkel\n \nGJE\n\n, \n\nAlgra\n \nA\n\n\n. \nLong-term outcomes of patients with aneurysmal subarachnoid haemorrhage\n. \nLancet Neurol\n. \n2011\n;\n10\n(\n4\n):\n349\n\u2013\n356\n.\n2143559910.1016\/S1474-4422(11)70017-5"},{"issue":"9558","key":"b11","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage","volume":"369","author":"van Gijn\n \nJ","year":"2007","unstructured":"van Gijn\n \nJ\n\n, \n\nKerr\n \nRS\n\n, \n\nRinkel\n \nGJ\n\n\n. \nSubarachnoid haemorrhage\n. \nLancet\n. \n2007\n;\n369\n(\n9558\n):\n306\n\u2013\n318\n.\n1725867110.1016\/S0140-6736(07)60153-6"},{"issue":"1-2","key":"b12","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000476073","article-title":"Is regular screening for intracranial aneurysm necessary in patients with autosomal dominant polycystic kidney disease? A systematic review and meta-analysis","volume":"44","author":"Zhou\n \nZ","year":"2017","unstructured":"Zhou\n \nZ\n\n, \n\nXu\n \nY\n\n, \n\nDelcourt\n \nC\n\n, \n\n\n \nIs regular screening for intracranial aneurysm necessary in patients with autosomal dominant polycystic kidney disease? A systematic review and meta-analysis\n. \nCerebrovasc Dis\n. \n2017\n;\n44\n(\n1-2\n):\n75\n\u2013\n82\n.\n10.1159\/00047607328502970"},{"issue":"12","key":"b13","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick\n \nGM","year":"1995","unstructured":"Fick\n \nGM\n\n, \n\nJohnson\n \nAM\n\n, \n\nHammond\n \nWS\n\n, \n\nGabow\n \nPA\n\n\n. \nCauses of death in autosomal dominant polycystic kidney disease\n. \nJ Am Soc Nephrol\n. \n1995\n;\n5\n(\n12\n):\n2048\n\u2013\n2056\n.\n10.1681\/ASN.V51220487579053"},{"issue":"3","key":"b14","series-title":"Kidney Int","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.kint.2017.08.016","article-title":"Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective","volume":"93","author":"Flahault\n \nA","year":"2018","unstructured":"Flahault\n \nA\n\n, \n\nTrystram\n \nD\n\n, \n\nNataf\n \nF\n\n, \n\n\n \nScreening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective\n. \nKidney Int\n. \n2018\n;\n93\n(\n3\n):\n716\n\u2013\n726\n.\n2906133110.1016\/j.kint.2017.08.016"},{"issue":"9376","key":"b15","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(03)13773-7","article-title":"Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype","volume":"361","author":"Rossetti\n \nS","year":"2003","unstructured":"Rossetti\n \nS\n\n, \n\nChauveau\n \nD\n\n, \n\nKubly\n \nV\n\n, \n\n\n \nAssociation of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype\n. \nLancet\n. \n2003\n;\n361\n(\n9376\n):\n2196\n\u2013\n2201\n.\n10.1016\/S0140-6736(03)13773-712842373"},{"issue":"18","key":"b16","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/WNL.0000000000004597","article-title":"Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population","volume":"89","author":"Nurmonen\n \nHJ","year":"2017","unstructured":"Nurmonen\n \nHJ\n\n, \n\nHuttunen\n \nT\n\n, \n\nHuttunen\n \nJ\n\n, \n\n\n \nPolycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population\n. \nNeurology\n. \n2017\n;\n89\n(\n18\n):\n1852\n\u2013\n1859\n.\n2897865910.1212\/WNL.0000000000004597"},{"issue":"8","key":"b17","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00701-018-3600-2","article-title":"Identification of potential organ donors after aneurysmal subarachnoid hemorrhage in a population-based neurointensive care in Eastern Finland","volume":"160","author":"K\u00e4m\u00e4r\u00e4inen\n \nOP","year":"2018","unstructured":"K\u00e4m\u00e4r\u00e4inen\n \nOP\n\n, \n\nHuttunen\n \nJ\n\n, \n\nLindgren\n \nA\n\n, \n\n\n \nIdentification of potential organ donors after aneurysmal subarachnoid hemorrhage in a population-based neurointensive care in Eastern Finland\n. \nActa Neurochir (Wien)\n. \n2018\n;\n160\n(\n8\n):\n1507\n\u2013\n1514\n.\n10.1007\/s00701-018-3600-2"},{"issue":"5","key":"b18","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/STROKEAHA.115.012573","article-title":"De novo aneurysm formation in carriers of saccular intracranial aneurysm disease in Eastern Finland","volume":"47","author":"Lindgren\n \nAE","year":"2016","unstructured":"Lindgren\n \nAE\n\n, \n\nR\u00e4is\u00e4nen\n \nS\n\n, \n\nBj\u00f6rkman\n \nJ\n\n, \n\n\n \nDe novo aneurysm formation in carriers of saccular intracranial aneurysm disease in Eastern Finland\n. \nStroke\n. \n2016\n;\n47\n(\n5\n):\n1213\n\u2013\n1218\n.\n10.1161\/STROKEAHA.115.01257327026632"},{"issue":"3","key":"b19","series-title":"Ann Med","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/07853890.2014.883168","article-title":"Hypertension predisposes to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland","volume":"46","author":"Lindgren\n \nAE","year":"2014","unstructured":"Lindgren\n \nAE\n\n, \n\nKurki\n \nMI\n\n, \n\nRiihinen\n \nA\n\n, \n\n\n \nHypertension predisposes to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland\n. \nAnn Med\n. \n2014\n;\n46\n(\n3\n):\n169\n\u2013\n176\n.\n10.3109\/07853890.2014.883168"},{"issue":"9","key":"b20","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.116.014327","article-title":"Antidepressant use after aneurysmal subarachnoid hemorrhage: a population-based case-control study","volume":"47","author":"Huttunen\n \nJ","year":"2016","unstructured":"Huttunen\n \nJ\n\n, \n\nLindgren\n \nA\n\n, \n\nKurki\n \nMI\n\n, \n\n\n \nAntidepressant use after aneurysmal subarachnoid hemorrhage: a population-based case-control study\n. \nStroke\n. \n2016\n;\n47\n(\n9\n):\n2242\n\u2013\n2248\n.\n10.1161\/STROKEAHA.116.01432727486167"},{"issue":"10","key":"b21","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0206432","DOI":"10.1371\/journal.pone.0206432","article-title":"Secondary hypertension in patients with saccular intracranial aneurysm disease: a population based study","volume":"13","author":"Kotikoski\n \nS","year":"2018","unstructured":"Kotikoski\n \nS\n\n, \n\nHuttunen\n \nJ\n\n, \n\nHuttunen\n \nTJ\n\n, \n\n\n \nSecondary hypertension in patients with saccular intracranial aneurysm disease: a population based study\n. \nPLoS One\n. \n2018\n;\n13\n(\n10\n):\ne0206432\n.\n10.1371\/journal.pone.020643230379949"},{"issue":"10","key":"b22","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1161\/STROKEAHA.116.013739","article-title":"Risk of shunting after aneurysmal subarachnoid hemorrhage: a collaborative study and initiation of a consortium","volume":"47","author":"Adams\n \nH","year":"2016","unstructured":"Adams\n \nH\n\n, \n\nBan\n \nVS\n\n, \n\nLeinonen\n \nV\n\n, \n\n\n \nRisk of shunting after aneurysmal subarachnoid hemorrhage: a collaborative study and initiation of a consortium\n. \nStroke\n. \n2016\n;\n47\n(\n10\n):\n2488\n\u2013\n2496\n.\n10.1161\/STROKEAHA.116.01373927633019"},{"issue":"1\u20132","key":"b23","series-title":"Neuroepidemiology","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000493856","article-title":"Saccular intracranial aneurysms in children when both parents are sporadic or familial carriers of saccular intracranial aneurysms","volume":"52","author":"Kurtelius\n \nA","year":"2019","unstructured":"Kurtelius\n \nA\n\n, \n\nKurki\n \nMI\n\n, \n\nvon Und Zu Fraunberg\n \nM\n\n, \n\n\n \nSaccular intracranial aneurysms in children when both parents are sporadic or familial carriers of saccular intracranial aneurysms\n. \nNeuroepidemiology\n. \n2019\n;\n52\n(\n1\u20132\n):\n47\n\u2013\n54\n.\n10.1159\/000493856"},{"issue":"9","key":"b24","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey\n \nAS","year":"2009","unstructured":"Levey\n \nAS\n\n, \n\nStevens\n \nLA\n\n, \n\nSchmid\n \nCH\n\n, \n\n\n \nA new equation to estimate glomerular filtration rate\n. \nAnn Intern Med\n. \n2009\n;\n150\n(\n9\n):\n604\n\u2013\n612\n.\n1941483910.7326\/0003-4819-150-9-200905050-00006"},{"issue":"4","key":"b25","series-title":"Kidney Int","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ki.1994.151","article-title":"Intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"45","author":"Chauveau\n \nD","year":"1994","unstructured":"Chauveau\n \nD\n\n, \n\nPirson\n \nY\n\n, \n\nVerellen-Dumoulin\n \nC\n\n, \n\n\n \nIntracranial aneurysms in autosomal dominant polycystic kidney disease\n. \nKidney Int\n. \n1994\n;\n45\n(\n4\n):\n1140\n\u2013\n1146\n.\n10.1038\/ki.1994.1518007584"},{"issue":"1","key":"b26","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/ASN.V3188","article-title":"Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"3","author":"Schievink\n \nWI","year":"1992","unstructured":"Schievink\n \nWI\n\n, \n\nTorres\n \nVE\n\n, \n\nPiepgras\n \nDG\n\n, \n\nWiebers\n \nDO\n\n\n. \nSaccular intracranial aneurysms in autosomal dominant polycystic kidney disease\n. \nJ Am Soc Nephrol\n. \n1992\n;\n3\n(\n1\n):\n88\n\u2013\n95\n.\n10.1681\/ASN.V31881391712"},{"issue":"4","key":"b27","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00415-003-0997-0","article-title":"Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease","volume":"250","author":"Gieteling\n \nEW","year":"2003","unstructured":"Gieteling\n \nEW\n\n, \n\nRinkel\n \nGJ\n\n\n. \nCharacteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease\n. \nJ Neurol\n. \n2003\n;\n250\n(\n4\n):\n418\n\u2013\n423\n.\n1270090510.1007\/s00415-003-0997-0"},{"issue":"6","key":"b28","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.wneu.2011.08.033","article-title":"Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage","volume":"78","author":"Karamanakos\n \nPN","year":"2012","unstructured":"Karamanakos\n \nPN\n\n, \n\nvon Und Zu Fraunberg\n \nM\n\n, \n\nBendel\n \nS\n\n, \n\n\n \nRisk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage\n. \nWorld Neurosurg\n. \n2012\n;\n78\n(\n6\n):\n631\n\u2013\n639\n.\n2212029310.1016\/j.wneu.2011.08.033"},{"issue":"2","key":"b29","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner\n \nT","year":"2013","unstructured":"Steiner\n \nT\n\n, \n\nJuvela\n \nS\n\n, \n\nUnterberg\n \nA\n\n, \n\n\n \nEuropean Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage\n. \nCerebrovasc Dis\n. \n2013\n;\n35\n(\n2\n):\n93\n\u2013\n112\n.\n2340682810.1159\/000346087"},{"issue":"1","key":"b30","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/STROKEAHA.108.517805","article-title":"Variation in outcome after subarachnoid hemorrhage: a study of neurosurgical units in UK and Ireland","volume":"40","author":"Langham\n \nJ","year":"2009","unstructured":"Langham\n \nJ\n\n, \n\nReeves\n \nBC\n\n, \n\nLindsay\n \nKW\n\n, \n\n\n \nVariation in outcome after subarachnoid hemorrhage: a study of neurosurgical units in UK and Ireland\n. \nStroke\n. \n2009\n;\n40\n(\n1\n):\n111\n\u2013\n118\n.\n1900847410.1161\/STROKEAHA.108.517805"},{"issue":"8","key":"b31","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","article-title":"Stroke and cerebrovascular diseases in patients with chronic kidney disease","volume":"13","author":"Toyoda\n \nK","year":"2014","unstructured":"Toyoda\n \nK\n\n, \n\nNinomiya\n \nT\n\n\n. \nStroke and cerebrovascular diseases in patients with chronic kidney disease\n. \nLancet Neurol\n. \n2014\n;\n13\n(\n8\n):\n823\n\u2013\n833\n.\n2503051410.1016\/S1474-4422(14)70026-2"},{"issue":"1\u20132","key":"b32","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2010.11.002","article-title":"Chronic kidney disease and risk of death during hospitalization for stroke","volume":"301","author":"Ovbiagele\n \nB","year":"2011","unstructured":"Ovbiagele\n \nB\n\n\n. \nChronic kidney disease and risk of death during hospitalization for stroke\n. \nJ Neurol Sci\n. \n2011\n;\n301\n(\n1\u20132\n):\n46\n\u2013\n50\n.\n2109495510.1016\/j.jns.2010.11.002"},{"issue":"5","key":"b33","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00701-017-3142-z","article-title":"Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review","volume":"159","author":"Cagnazzo\n \nF","year":"2017","unstructured":"Cagnazzo\n \nF\n\n, \n\nGambacciani\n \nC\n\n, \n\nMorganti\n \nR\n\n, \n\nPerrini\n \nP\n\n\n. \nIntracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review\n. \nActa Neurochir (Wien)\n. \n2017\n;\n159\n(\n5\n):\n811\n\u2013\n821\n.\n10.1007\/s00701-017-3142-z28283868"},{"issue":"5","key":"b34","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/neuros\/nyy161","article-title":"Aneurysm size is the strongest risk factor for intracranial aneurysm growth in the Eastern Finnish population","volume":"84","author":"Bj\u00f6rkman\n \nJ","year":"2019","unstructured":"Bj\u00f6rkman\n \nJ\n\n, \n\nFr\u00f6sen\n \nJ\n\n, \n\nT\u00e4htinen\n \nO\n\n, \n\n\n \nAneurysm size is the strongest risk factor for intracranial aneurysm growth in the Eastern Finnish population\n. \nNeurosurgery\n. \n2019\n;\n84\n(\n5\n):\n1098\n\u2013\n1103\n.\n10.1093\/neuros\/nyy16129767773"},{"issue":"22","key":"b35","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1212\/WNL.0000000000001643","article-title":"Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study","volume":"84","author":"Huttunen\n \nJ","year":"2015","unstructured":"Huttunen\n \nJ\n\n, \n\nKurki\n \nMI\n\n, \n\nvon Und Zu Fraunberg\n \nM\n\n, \n\n\n \nEpilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study\n. \nNeurology\n. \n2015\n;\n84\n(\n22\n):\n2229\n\u2013\n2237\n.\n10.1212\/WNL.000000000000164325948726"},{"issue":"3","key":"b36","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1212\/WNL.0000000000004113","article-title":"Epilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage","volume":"89","author":"Huttunen\n \nJ","year":"2017","unstructured":"Huttunen\n \nJ\n\n, \n\nLindgren\n \nA\n\n, \n\nKurki\n \nMI\n\n, \n\n\n \nEpilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage\n. \nNeurology\n. \n2017\n;\n89\n(\n3\n):\n263\n\u2013\n268\n.\n10.1212\/WNL.000000000000411328615425"},{"issue":"2","key":"b37","series-title":"Neuroepidemiology","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000335041","article-title":"Increased relative risk of lung cancer in 2,904 patients with saccular intracranial aneurysm disease in Eastern Finland","volume":"38","author":"Huttunen\n \nT","year":"2012","unstructured":"Huttunen\n \nT\n\n, \n\nRiihinen\n \nA\n\n, \n\nPukkala\n \nE\n\n, \n\n\n \nIncreased relative risk of lung cancer in 2,904 patients with saccular intracranial aneurysm disease in Eastern Finland\n. \nNeuroepidemiology\n. \n2012\n;\n38\n(\n2\n):\n93\n\u2013\n99\n.\n2234318610.1159\/000335041"},{"issue":"7","key":"b38","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STROKEAHA.119.024914","article-title":"Antipsychotic use among 1144 patients after aneurysmal subarachnoid hemorrhage: a population-based case-control study","volume":"50","author":"Paavola\n \nJT","year":"2019","unstructured":"Paavola\n \nJT\n\n, \n\nV\u00e4ntti\n \nN\n\n, \n\nJunkkari\n \nA\n\n, \n\n\n \nAntipsychotic use among 1144 patients after aneurysmal subarachnoid hemorrhage: a population-based case-control study\n. \nStroke\n. \n2019\n;\n50\n(\n7\n):\n1711\n\u2013\n1718\n.\n3116761710.1161\/STROKEAHA.119.024914"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/134\/6\/article-p1871.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/134\/6\/article-p1871.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/134\/6\/article-p1871.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:52:55Z","timestamp":1792198375000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/134\/6\/article-p1871.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":38,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2020.4.jns20544","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}